An official website of the United States government
NIH Guide: Weekly Index for August 30, 2024
Weekly NIH Guide Notices
August 30, 2024
General Notices
-
Notice of Pre-Application Webinar for RFA-CA-24-029, "RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)" Program
(NOT-CA-24-101)National Cancer Institute
-
Notice of Technical Assistance Webinar and Networking Webinar for RFA-NS-24-041 "NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional)"
(NOT-NS-24-133)National Institute of Neurological Disorders and Stroke
-
Review of the Accuracy of Grants Information for Fiscal Year 2024
(NOT-OD-24-167)National Institutes of Health
-
Request for Information (RFI): NICHD Strategic Plan 2025
(NOT-HD-24-028)Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Changes to Funding Opportunities
-
Notice of NHGRI Withdrawal of Participation From PA-24-191 "Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)"
(NOT-HG-24-046)National Human Genome Research Institute
-
Notice of Change to Research Opportunity: Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional).
(NOT-HS-24-021)Agency for Healthcare Research and Quality
-
Notice to Extend Expiration Dates for PA-21-264 and PA-21-265
(NOT-HS-24-022)Agency for Healthcare Research and Quality
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)
(NOT-HL-24-027)National Heart, Lung, and Blood Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): An Annual Scientific Meeting to Support the Chemical Countermeasures Research Program (CCRP)
(NOT-AI-24-066)National Institute of Allergy and Infectious DiseasesNational Institute on Drug AbuseNational Eye InstituteNational Institute of Neurological Disorders and Stroke
-
Notice of Special Interest (NOSI): Model-informed Drug Development (MIDD) Approaches to Facilitate the Development of Therapeutics for Substance Use Disorders
(NOT-DA-26-002)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Advancing Precision Imaging for Enhanced Diagnosis and Treatment of Oral Lesions
(NOT-DE-25-034)National Institute of Dental and Craniofacial Research
-
Notice of Special Interest (NOSI): Administrative Supplement Program to Add Fluid-based Biomarkers and APOE Genotyping to NINDS ADRD Human Subjects Research Grants
(NOT-NS-24-109)National Institute of Neurological Disorders and StrokeNational Institute on Aging
Funding Opportunities
-
Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
(PAR-24-258)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Deafness and Other Communication DisordersNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
(PAR-24-273)National Institute on Minority Health and Health DisparitiesNational Institute on AgingNational Cancer InstituteNational Institute of Nursing ResearchOffice of Disease PreventionApplication Receipt Date(s): Multiple dates, see announcement.
-
NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed)
(PAR-24-281)National Library of MedicineOffice of Research on Women's HealthApplication Receipt Date(s): May 25, 2026
-
The Impact of Stressors on the Biological Mechanisms of Aging and Other Aging-Associated Outcomes in Experimental Model Systems (R61/R33 Clinical Trial Not allowed)
(RFA-AG-25-019)National Institute on AgingApplication Receipt Date(s): November 07, 2024
-
Short Courses Promoting Cross-National Analyses Using Data from the International Health and Retirement Study (HRS) and Harmonized Cognitive Assessment Protocol (HCAP) (R25 Clinical Trial Not Allowed)
(RFA-AG-25-025)National Institute on AgingApplication Receipt Date(s): November 01, 2024
-
Understanding the mechanisms underlying the age-related changes in gait biomechanics and the impact on the increased metabolic cost of walking (R01 Clinical Trial Optional)
(RFA-AG-25-030)National Institute on AgingApplication Receipt Date(s): November 07, 2024
-
Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
(RFA-AI-24-057)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Not Applicable
-
Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
(RFA-AI-24-064)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Not Applicable
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster